CCL2 and colitis: The downregulation in the expression of the MIP-2 and MCP-1 chemokines, and of the ICAM-1 adhesion molecule by the HEBP improved colonic inflammation in both experimental colitis models, thus resulting in reduced migration and penetration of inflammatory cells into the intestinal mucosa.